Community Perspectives on Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndrome

preview_player
Показать описание
Join experts on treating higher-risk myelodysplastic syndromes and acute myeloid leukemia.

Supported by independent educational grants from AbbVie; Actinium Pharmaceuticals; Biomea Fusion; Gilead Sciences, Inc.; GlycoMimetics, Inc.; and Rigel Pharmaceuticals, Inc.
Рекомендации по теме